Skip to main content

Table 3 Correlates of ACS ISR presentation compared to non-ACS presentation

From: In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

VariablesUnivariate analysisMultivariate analysis
ORLower 95% CIUpper 95% CIP valueORLower 95% CIUpper 95% CIP value
Patient-related
 Age1.030.991.060.0761.010.981.050.449
 Female gender2.531.085.900.0322.711.136.520.026
 BMI1.040.931.170.476
 Diabetes1.060.591.910.843
 Hypertension1.170.652.100.601
 Current tobacco use0.760.371.540.440
 Dyslipidemia1.560.763.210.224
 Chronic kidney disease4.201.1914.800.0263.851.0514.200.043
 CCF5.881.9817.490.0014.981.6315.260.005
 Previous MI1.330.742.390.338
 Previous CABG1.120.363.490.841
 Statin therapy0.730.311.720.475    
Lesion-related
 LAD involvement0.710.391.280.248
 Proximal ISR location0.880.491.580.656
  1. ACS acute coronary syndrome, BMI body mass index, CABG coronary artery bypass grafting, CCF congestive cardiac failure, CI confidence interval, ISR in-stent restenosis, LAD left anterior descending, LVEF left ventricular ejection fraction, MI myocardial infarction, OR odds ratio